adebrelimab combined with chemotherapy

DRUG2 trials

Sponsors

The Second Hospital of Shandong University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Immune-related Adverse EventsLocally Advanced Resectable Rectal CancerObjective Response RatePathological Complete RemissionQuality of Life

Phase 2

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

RecruitingNCT07454720

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Locally Advanced Resectable Rectal Cancer

Start: 2026-03-23End: 2035-11-01Target: 165Updated: 2026-05-05

Unknown Phase

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

RecruitingNCT07430579

The Second Hospital of Shandong UniversityImmune-related Adverse Events, Objective Response Rate, Pathological Complete Remission +1

Start: 2024-12-09End: 2028-06-30Target: 25Updated: 2026-02-24